Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil dosing regimens during induction–delivery period of cesarean section under general anesthesia
DRKS00015114Phase 4Completed
- Sponsor
- Clinic of Gynaecology and Obstetrics, University Clinical Centre Niš
- Start
- Jul 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remifentanil in oxidative stress (3 arms), sponsored by Clinic of Gynaecology and Obstetrics, University Clinical Centre Niš. Primary endpoints: Maternal hemodynamic response during induction–delivery period, Maternal oxidative stress response and 1 more. Started Jul 2018; status: completed.
02
Drugs
remifentanil
03
Conditions
oxidative stress
Beyond the preview
Go deeper on DRKS00015114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00015114.